{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:13:48Z","timestamp":1762899228038},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T00:00:00Z","timestamp":1454716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T00:00:00Z","timestamp":1454716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Malaria infection is still widespread in some parts of the world and threatens the lives of millions of people every year. Vaccines, especially oral vaccines are considered to be effective in reducing the burden of malaria morbidity and mortality. By using recombinant technology, suitable oral hosts could serve as antigen delivering vehicles in developing oral vaccines. This study was aimed towards designing and computational analysis of a fusion protein consisting of <jats:italic>Plasmodium falciparum<\/jats:italic> cell-traversal protein for ookinetes and sporozoites (<jats:italic>Pf<\/jats:italic>CelTOS) fused to human interleukin-2 (IL-2) and M cell-specific peptide ligand (Co1), as a step toward developing a vaccine candidate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>To our best knowledge, the three dimensional (3D) structure of CelTOS is not reported in protein database. Therefore, we carried out computational modeling and simulation in the hope of understanding the properties and structure of <jats:italic>Pf<\/jats:italic>CelTOS. Then we fused IL-2 to <jats:italic>Pf<\/jats:italic>CelTOS by a flexible linker and did in silico analysis to confirm the proper folding of each domain in the designed fusion protein. In the last step, Co1 ligand was added to the confirmed fusion structure using a rigid linker and computational analysis was performed to evaluate the final fusion construct. One structure out of five predicted by I-TASSER for <jats:italic>Pf<\/jats:italic>CelTOS and fusion constructs was selected based on the highest value for C-score. Molecular dynamics (MD) simulation analysis indicated that predicted structures are stable during the simulation. Ramchandran Plot analysis of <jats:italic>Pf<\/jats:italic>CelTOS and fusion constructs before and after MD simulation also represented that most residues were fallen in favorable regions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In silico study showed that Co1-(AEEEK)<jats:sub>3<\/jats:sub>- IL-2-(GGGGS)<jats:sub>3<\/jats:sub>-PfCelTOS construct has a constant structure and the selected linkers are effectively able to separate the domains. Therefore, data reported in this paper represents the first step toward developing of an oral vaccine candidate against malaria infection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-016-0918-8","type":"journal-article","created":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T04:40:50Z","timestamp":1454733650000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Design, structure prediction and molecular dynamics simulation of a fusion construct containing malaria pre-erythrocytic vaccine candidate, PfCelTOS, and human interleukin 2 as adjuvant"],"prefix":"10.1186","volume":"17","author":[{"given":"Shabnam","family":"Shamriz","sequence":"first","affiliation":[]},{"given":"Hamideh","family":"Ofoghi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,2,6]]},"reference":[{"issue":"Suppl 2","key":"918_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-0691.12418","volume":"20","author":"S Debast","year":"2014","unstructured":"Debast S, Bauer M, Kuijper E, European Society of Clinical Microbiology and Infectious Diseases. European society of clinical microbiology and infectious diseases: update of the treatment guidance document for clostridium difficile infection. Clin Microbiol Infect. 2014;20 Suppl 2:1\u201326.","journal-title":"Clin Microbiol Infect"},{"key":"918_CR2","unstructured":"Brower J, Chalk P. The global threat of new and reemerging infectious diseases: reconciling US national security and public health policy. Rand Corporation; 2003"},{"key":"918_CR3","unstructured":"WHO. World malaria report 2013. World Health Organization; 2014"},{"key":"918_CR4","doi-asserted-by":"crossref","unstructured":"O\u2019Brien C, Henrich P, Passi N, Fridock D. Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr Opin Infect Dis. 2011;24(6):570.","DOI":"10.1097\/QCO.0b013e32834cd3ed"},{"issue":"6","key":"918_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2217\/fmb.11.45","volume":"6","author":"C McNamara","year":"2011","unstructured":"McNamara C, Winzeler EA. Target identification and validation of novel antimalarials. Future Microbiol. 2011;6(6):693\u2013704.","journal-title":"Future Microbiol"},{"key":"918_CR6","doi-asserted-by":"crossref","unstructured":"Ranson H, N\u2019Guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V. Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol. 2011;27(2):91\u20138.","DOI":"10.1016\/j.pt.2010.08.004"},{"key":"918_CR7","doi-asserted-by":"crossref","unstructured":"Ingstad B, Munthali A, Braathen S, Grut L. The evil circle of poverty: a qualitative study of malaria and disability. Malar J. 2012;11(11):15.","DOI":"10.1186\/1475-2875-11-15"},{"key":"918_CR8","first-page":"1","volume":"1","author":"K Dhama","year":"2013","unstructured":"Dhama K et al. Plant based oral vaccines for human and animal pathogens-a new era of prophylaxis: Current and future prospective. J Exp Biol Agric Sci. 2013;1:1\u201312.","journal-title":"J Exp Biol Agric Sci"},{"issue":"8","key":"918_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3251","volume":"12","author":"N Lycke","year":"2012","unstructured":"Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol. 2012;12(8):592\u2013605.","journal-title":"Nat Rev Immunol"},{"key":"918_CR10","doi-asserted-by":"crossref","unstructured":"Czerkinsky C, Holmgren J. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues. Mucosal Vaccines, Springer. 2010;354:1-18.\u00a0","DOI":"10.1007\/82_2010_112"},{"issue":"1","key":"918_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","volume":"239","author":"MF Pasetti","year":"2011","unstructured":"Pasetti MF et al. Immunology of gut mucosal vaccines. Immunol Rev. 2011;239(1):125\u201348.","journal-title":"Immunol Rev"},{"key":"918_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fimmu.2015.00288","volume":"6","author":"JD Price","year":"2015","unstructured":"Price JD, Tarbell KV. The role of dendritic cell subsets and innate immunity in the pathogenesis of type 1 diabetes and other autoimmune diseases. Front Immunol. 2015;6:288.","journal-title":"Front Immunol"},{"issue":"20","key":"918_CR13","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.2174\/15680266113136660186","volume":"13","author":"J-P Kraehenbuhl","year":"2013","unstructured":"Kraehenbuhl J-P, Neutra MR. Mucosal vaccines: where do we stand? Curr Top Med Chem. 2013;13(20):2609\u201328.","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"918_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.7774\/cevr.2012.1.1.50","volume":"1","author":"JH Rhee","year":"2012","unstructured":"Rhee JH, Lee SE, Kim SY. Mucosal vaccine adjuvants update. Clin Exp Vaccine Res. 2012;1(1):50\u201363.","journal-title":"Clin Exp Vaccine Res"},{"key":"918_CR15","doi-asserted-by":"crossref","unstructured":"Newsted D, Fallahi F, Golshani A, Azizi A. Advances and challenges in mucosal adjuvant technology. Vaccine. 2015;33(21):2399\u2013405.","DOI":"10.1016\/j.vaccine.2015.03.096"},{"key":"918_CR16","doi-asserted-by":"crossref","unstructured":"Kariu T, Ishino T, Yano K, Chinzei Y, Yuda M. CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Mol Microbiol. 2006;59(5):1369\u201379.","DOI":"10.1111\/j.1365-2958.2005.05024.x"},{"key":"918_CR17","doi-asserted-by":"crossref","unstructured":"Bergmann-Leitner E, Legler P, Savranskaya T, Ockenhouse C, Angov E. Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS. Vaccine. 2011;29(35):5940\u20139.","DOI":"10.1016\/j.vaccine.2011.06.053"},{"key":"918_CR18","doi-asserted-by":"crossref","unstructured":"Bergmann-Leitner E, Li Q, Caridha D, O\u2019Neil M, Ockenhouse C, Hickman M, Angov E. Protective immune mechanisms against pre-erythrocytic forms of Plasmodium berghei depend on the target antigen. Trials Vaccinology. 2014;3:6\u201310.","DOI":"10.1016\/j.trivac.2013.11.002"},{"key":"918_CR19","doi-asserted-by":"crossref","unstructured":"Bergmann-Leitner E, Mease R, Vega P, Savranskaya T, Polhemus M, Ockenhouse C, Angov E. Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei. Plos one. 2010;5(8):1-9.","DOI":"10.1371\/journal.pone.0012294"},{"key":"918_CR20","doi-asserted-by":"crossref","unstructured":"Giedlin M.A. Cytokines as vaccine adjuvants: the use of interleukin-2. Vaccine Adjuvants, Springer. 2000;42:283\u2013297.","DOI":"10.1385\/1-59259-083-7:283"},{"issue":"2","key":"918_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nm.3083","volume":"19","author":"EM Riley","year":"2013","unstructured":"Riley EM, Stewart VA. Immune mechanisms in malaria: new insights in vaccine development. Nature Med. 2013;19(2):168\u201378.","journal-title":"Nature Med"},{"key":"918_CR22","doi-asserted-by":"crossref","unstructured":"Nohria A, Rubin RH. Cytokines as potential vaccine adjuvants. chapter: Cytokines in the Treatment of Infectious Diseases, Springer. 1995;261\u20139.","DOI":"10.1007\/978-94-011-0233-9_12"},{"issue":"1\u201310","key":"918_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1439-0450.1997.tb01013.x","volume":"44","author":"D Derosa","year":"1997","unstructured":"Derosa D, Sordillo L. Efficacy of a Bovine Staphylococcus aureus Vaccine using Interleukin\u20102 as an Adjuvant. J Veterinary Med Ser B. 1997;44(1\u201310):599\u2013607.","journal-title":"J Veterinary Med Ser B"},{"key":"918_CR24","doi-asserted-by":"crossref","unstructured":"Zhang H, Qiu Y, \u00a0Zhao Y, Liu X, Liu M, Yu A. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant. Mol Cell Probes. 2014;28(1):25\u201330.","DOI":"10.1016\/j.mcp.2013.08.003"},{"key":"918_CR25","doi-asserted-by":"crossref","unstructured":"Nunberg J, Doyle M, York S, York C. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc Natl Acad Sci. 1989;86(11):4240\u20133.","DOI":"10.1073\/pnas.86.11.4240"},{"key":"918_CR26","unstructured":"Overwijk WW, Theoret MR, Restifo NP. The future of interleukin-2: enhancing therapeutic anticancer vaccines. Cancer J Sci Am. 2000;6(Suppl 1):S76\u2013S80.\u00a0"},{"key":"918_CR27","doi-asserted-by":"crossref","unstructured":"Kim S, \u00a0Seo K, Kim J, Lee K, Jang Y. The M cell-targeting ligand promotes antigen delivery and induces antigen-specific immune responses in mucosal vaccination. J Immunol. 2010;185(10):5787\u201395.","DOI":"10.4049\/jimmunol.0903184"},{"key":"918_CR28","doi-asserted-by":"crossref","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins M, Appel R, Bairoch A. Protein identification and analysis tools on the ExPASy server. Springer; 2005.","DOI":"10.1385\/1-59259-890-0:571"},{"issue":"2","key":"918_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/protein\/4.2.155","volume":"4","author":"K Guruprasad","year":"1990","unstructured":"Guruprasad K, Reddy BB, Pandit MW. Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng. 1990;4(2):155\u201361.","journal-title":"Protein Eng"},{"issue":"6","key":"918_CR30","first-page":"1895","volume":"88","author":"I Atsushi","year":"1980","unstructured":"Atsushi I. Thermostability and aliphatic index of globular proteins. J Biochem. 1980;88(6):1895\u20138.","journal-title":"J Biochem"},{"issue":"1","key":"918_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157(1):105\u201332.","journal-title":"J Mol Biol"},{"key":"918_CR32","doi-asserted-by":"crossref","unstructured":"Kelley L, Mezulis S, Yates C, \u00a0Wass M, Sternberg M. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10(6):845\u201358.","DOI":"10.1038\/nprot.2015.053"},{"key":"918_CR33","doi-asserted-by":"crossref","unstructured":"Yang J, Yan R, Roy A, \u00a0Xu D, Poisson J, Zhang Y. The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2015;12(1):7\u20138.","DOI":"10.1038\/nmeth.3213"},{"key":"918_CR34","volume-title":"The PyMOL molecular graphics system","author":"WL DeLano","year":"2002","unstructured":"DeLano WL. The PyMOL molecular graphics system. 2002."},{"issue":"3","key":"918_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/B:JCAM.0000035186.90683.f2","volume":"18","author":"A Pedretti","year":"2004","unstructured":"Pedretti A, Villa L, Vistoli G. VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming. J Comput Aided Mol Des. 2004;18(3):167\u201373.","journal-title":"J Comput Aided Mol Des"},{"key":"918_CR36","doi-asserted-by":"crossref","unstructured":"Lovell S, Davis I, Arendall III B, Bakker P, Word M, Prisant M, Richardson J, Richardson D. Structure validation by C\u03b1 geometry: \u03d5, \u03c8 and C\u03b2 deviation. Proteins: Struct, Funct, Bioinf. 2003;50(3):437\u201350.","DOI":"10.1002\/prot.10286"},{"key":"918_CR37","unstructured":"Hess BD, van der Spoel, Lindahl E. GROMACS Groningen Machine for Chemical Simulations. User Manual. Version 4.5. 4."},{"key":"918_CR38","doi-asserted-by":"crossref","unstructured":"Abraham M, Hess B, Spoel D, Lindahl E. GROMACS User Manual version 5.0.1. 2014. http:\/\/www.gromacs.org.","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"918_CR39","first-page":"1","volume":"23","author":"MP Allen","year":"2004","unstructured":"Allen MP. Introduction to molecular dynamics simulation. Computational Soft Matter: Synthetic Polymers Proteins. 2004;23:1\u201328.","journal-title":"Computational Soft Matter: Synthetic Polymers Proteins"},{"key":"918_CR40","doi-asserted-by":"crossref","unstructured":"Ju G, Collins L, Kaffka KL, Tsien WH, Chizzonite R, Crow R, Bhatt R, Kilian PL. Structure-function analysis of human interleukin-2. Identification of amino acid residues required for biological activity. J Biol Chem. 1987;262(12):5723\u201331.","DOI":"10.1016\/S0021-9258(18)45635-9"},{"issue":"6","key":"918_CR41","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/bip.20291","volume":"80","author":"W Wriggers","year":"2005","unstructured":"Wriggers W, Chakravarty S, Jennings PA. Control of protein functional dynamics by peptide linkers. Pept Sci. 2005;80(6):736\u201346.","journal-title":"Pept Sci"},{"key":"918_CR42","unstructured":"Astuti A, Mutiara A. Performance Analysis on Molecular Dynamics Simulation of Protein Using GROMACS. arXiv preprint arXiv:0912.0893. 2009."},{"issue":"2","key":"918_CR43","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1006\/jmbi.1994.1017","volume":"235","author":"VN Maiorov","year":"1994","unstructured":"Maiorov VN, Crippen GM. Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins. J Mol Biol. 1994;235(2):625\u201334.","journal-title":"J Mol Biol"},{"issue":"4","key":"918_CR44","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov MY, Bogatyreva N, Galzitskaya O. Radius of gyration as an indicator of protein structure compactness. Mol Biol. 2008;42(4):623\u20138.","journal-title":"Mol Biol"},{"key":"918_CR45","unstructured":"Konermann L, Wilson DJ, Simmons DA. Stopped-flow Electrospray Ionization Mass Spectrometry. Methods in Protein Structure and Stability Analysis: NMR and EPR Spectroscopies, Mass-Spectrometry and Protein Imaging. Chapter 2.1. pp. 95-119"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-0918-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-016-0918-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-0918-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-0918-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T18:13:05Z","timestamp":1706811185000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-016-0918-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1186\/s12859-016-0918-8","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,6]]},"assertion":[{"value":"6 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"71"}}